Our scientists are focused on identifying novel genes and pathways involved in the development of autoimmune disorders such as systemic lupus erythematosus (SLE), Type 1 diabetes and rheumatoid arthritis. By studying the molecular targets impacting these genetic alterations, we aim to advance diagnostic techniques and develop innovative therapies that target and treat more effectively. Ultimately, our goal is to improve treatment options and pave the way for potential cures for these debilitating conditions.